Pediatric spinal glioblastoma multiforme

Current treatment strategies and possible predictors of survival

Chiagozie Ononiwu, Vivek Mehta, Chetan Bettegowda, George Jallo

Research output: Contribution to journalArticle

Abstract

Purpose: Pediatric spinal glioblastoma multiforme (GBM) is rare. Evidence-directed management relies on studies in which such cases are only a subset of a larger group. We reviewed cases of pediatric spinal GBM to assess outcomes and identify prognostic factors related to treatment. Methods: Clinical presentations, radiologic findings, surgical variables, radio- and chemotherapeutic management, and outcomes of eight pathologically proven cases of pediatric spinal GBM were reviewed. Results: Median age was 10 years. All patients presented with motor deficits. Four had sensory symptoms. Average McCormick score at presentation was II. There were three cervical, one cervicothoracic, and four thoracic tumors. Five had cysts. Patients underwent gross total resection (GTR) (n=4), subtotal resection (STR) (n=3), or biopsy (n=1). Four patients improved neurologically after surgery. One patient was lost to follow-up. Seven received both chemo- and radiotherapy. Average overall survival was 15 months. Average survival after STR and GTR were 12.6 and 19.2 months, respectively. In the GTR subset, the 18-month-old patient survived 30 months, while the other two (>10 years) survived an average of 13.75 months. This difference based on age was not seen in the STR subset. Patients survived an average of 17.5 and 10.5 months, respectively, with and without tumoral cysts. Patients with cervical tumors survived an average of 12.5 months, 18.7 months with thoracic tumors, and 11.5 months with a cervicothoracic tumor. Conclusions: Tumor location, presence of a cyst, gross total resection, and younger age are possible predictors of prolonged survival. Radiotherapy and chemotherapy remain widely used.

Original languageEnglish (US)
Pages (from-to)715-720
Number of pages6
JournalChild's Nervous System
Volume28
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Glioblastoma
Pediatrics
Survival
Cysts
Neoplasms
Therapeutics
Radiotherapy
Thorax
Drug Therapy
Lost to Follow-Up
Radio
Biopsy

Keywords

  • Glioblastoma
  • Pediatric
  • Spine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Pediatric spinal glioblastoma multiforme : Current treatment strategies and possible predictors of survival. / Ononiwu, Chiagozie; Mehta, Vivek; Bettegowda, Chetan; Jallo, George.

In: Child's Nervous System, Vol. 28, No. 5, 05.2012, p. 715-720.

Research output: Contribution to journalArticle

@article{8948a1b0c87a43d992311bd04f0f50fc,
title = "Pediatric spinal glioblastoma multiforme: Current treatment strategies and possible predictors of survival",
abstract = "Purpose: Pediatric spinal glioblastoma multiforme (GBM) is rare. Evidence-directed management relies on studies in which such cases are only a subset of a larger group. We reviewed cases of pediatric spinal GBM to assess outcomes and identify prognostic factors related to treatment. Methods: Clinical presentations, radiologic findings, surgical variables, radio- and chemotherapeutic management, and outcomes of eight pathologically proven cases of pediatric spinal GBM were reviewed. Results: Median age was 10 years. All patients presented with motor deficits. Four had sensory symptoms. Average McCormick score at presentation was II. There were three cervical, one cervicothoracic, and four thoracic tumors. Five had cysts. Patients underwent gross total resection (GTR) (n=4), subtotal resection (STR) (n=3), or biopsy (n=1). Four patients improved neurologically after surgery. One patient was lost to follow-up. Seven received both chemo- and radiotherapy. Average overall survival was 15 months. Average survival after STR and GTR were 12.6 and 19.2 months, respectively. In the GTR subset, the 18-month-old patient survived 30 months, while the other two (>10 years) survived an average of 13.75 months. This difference based on age was not seen in the STR subset. Patients survived an average of 17.5 and 10.5 months, respectively, with and without tumoral cysts. Patients with cervical tumors survived an average of 12.5 months, 18.7 months with thoracic tumors, and 11.5 months with a cervicothoracic tumor. Conclusions: Tumor location, presence of a cyst, gross total resection, and younger age are possible predictors of prolonged survival. Radiotherapy and chemotherapy remain widely used.",
keywords = "Glioblastoma, Pediatric, Spine",
author = "Chiagozie Ononiwu and Vivek Mehta and Chetan Bettegowda and George Jallo",
year = "2012",
month = "5",
doi = "10.1007/s00381-012-1705-0",
language = "English (US)",
volume = "28",
pages = "715--720",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Pediatric spinal glioblastoma multiforme

T2 - Current treatment strategies and possible predictors of survival

AU - Ononiwu, Chiagozie

AU - Mehta, Vivek

AU - Bettegowda, Chetan

AU - Jallo, George

PY - 2012/5

Y1 - 2012/5

N2 - Purpose: Pediatric spinal glioblastoma multiforme (GBM) is rare. Evidence-directed management relies on studies in which such cases are only a subset of a larger group. We reviewed cases of pediatric spinal GBM to assess outcomes and identify prognostic factors related to treatment. Methods: Clinical presentations, radiologic findings, surgical variables, radio- and chemotherapeutic management, and outcomes of eight pathologically proven cases of pediatric spinal GBM were reviewed. Results: Median age was 10 years. All patients presented with motor deficits. Four had sensory symptoms. Average McCormick score at presentation was II. There were three cervical, one cervicothoracic, and four thoracic tumors. Five had cysts. Patients underwent gross total resection (GTR) (n=4), subtotal resection (STR) (n=3), or biopsy (n=1). Four patients improved neurologically after surgery. One patient was lost to follow-up. Seven received both chemo- and radiotherapy. Average overall survival was 15 months. Average survival after STR and GTR were 12.6 and 19.2 months, respectively. In the GTR subset, the 18-month-old patient survived 30 months, while the other two (>10 years) survived an average of 13.75 months. This difference based on age was not seen in the STR subset. Patients survived an average of 17.5 and 10.5 months, respectively, with and without tumoral cysts. Patients with cervical tumors survived an average of 12.5 months, 18.7 months with thoracic tumors, and 11.5 months with a cervicothoracic tumor. Conclusions: Tumor location, presence of a cyst, gross total resection, and younger age are possible predictors of prolonged survival. Radiotherapy and chemotherapy remain widely used.

AB - Purpose: Pediatric spinal glioblastoma multiforme (GBM) is rare. Evidence-directed management relies on studies in which such cases are only a subset of a larger group. We reviewed cases of pediatric spinal GBM to assess outcomes and identify prognostic factors related to treatment. Methods: Clinical presentations, radiologic findings, surgical variables, radio- and chemotherapeutic management, and outcomes of eight pathologically proven cases of pediatric spinal GBM were reviewed. Results: Median age was 10 years. All patients presented with motor deficits. Four had sensory symptoms. Average McCormick score at presentation was II. There were three cervical, one cervicothoracic, and four thoracic tumors. Five had cysts. Patients underwent gross total resection (GTR) (n=4), subtotal resection (STR) (n=3), or biopsy (n=1). Four patients improved neurologically after surgery. One patient was lost to follow-up. Seven received both chemo- and radiotherapy. Average overall survival was 15 months. Average survival after STR and GTR were 12.6 and 19.2 months, respectively. In the GTR subset, the 18-month-old patient survived 30 months, while the other two (>10 years) survived an average of 13.75 months. This difference based on age was not seen in the STR subset. Patients survived an average of 17.5 and 10.5 months, respectively, with and without tumoral cysts. Patients with cervical tumors survived an average of 12.5 months, 18.7 months with thoracic tumors, and 11.5 months with a cervicothoracic tumor. Conclusions: Tumor location, presence of a cyst, gross total resection, and younger age are possible predictors of prolonged survival. Radiotherapy and chemotherapy remain widely used.

KW - Glioblastoma

KW - Pediatric

KW - Spine

UR - http://www.scopus.com/inward/record.url?scp=84859849004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859849004&partnerID=8YFLogxK

U2 - 10.1007/s00381-012-1705-0

DO - 10.1007/s00381-012-1705-0

M3 - Article

VL - 28

SP - 715

EP - 720

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 5

ER -